Co-Authors
This is a "connection" page, showing publications co-authored by Michael Joyner and Liise-Anne Pirofski.
Connection Strength
2.268
-
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy. Clin Infect Dis. 2021 08 02; 73(3):e540-e542.
Score: 0.240
-
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151.
Score: 0.237
-
Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 08; 61(8):2503-2511.
Score: 0.237
-
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities. J Clin Invest. 2021 04 01; 131(7).
Score: 0.234
-
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19. mBio. 2021 03 02; 12(2).
Score: 0.233
-
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275.
Score: 0.232
-
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. N Engl J Med. 2021 01 14; 384(2):189.
Score: 0.230
-
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114.
Score: 0.226
-
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457.
Score: 0.224
-
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
Score: 0.060
-
The Assessment of Convalescent Plasma Efficacy against COVID-19. Med (N Y). 2020 Dec 18; 1(1):66-77.
Score: 0.057
-
Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765.
Score: 0.055